Copper tripeptide-1 has been used in topical cosmetic formulations since the 1980s and is registered under the INCI nomenclature
Trientine diHClide is another common copper chelator used for treating Wilson's disease (132), which can selectively bind Cu2+ ions to improve mitochondrial function in patients with hypertrophic cardiomyopathy (73), as well as restore mitochondrial function and normalize myocardial expression and enzymatic activity of proteins involved in energy metabolism among diabetic patients (133)
(12) Insomnia and poor sleep habits can lead to decreased levels
They can disrupt the body's natural processes in many ways: mitochondrial function, stress hormone production, brain function, adrenal function, thyroid T4/T3 conversion, immune system regulation, virus susceptibility, reduced glutathione stores, increased inflammation, and reduced detoxification
Third-Party Independent Analytical Testing Available Upon Request for Additional Transparency & Assurance
It is strictly intended for in vitro research by qualified professionals